This paper brings up key findings and summarises a discussion on "Generic Pharmaceuticals" held in June 2014.
Competition and Generic Pharmaceuticals
Policy paper
OECD Roundtables on Competition Policy Papers

Share
Facebook
Twitter
LinkedIn